Cargando…
Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria
Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Rep...
Autores principales: | Lee, Hyo-Jin, Lee, Dong-Gun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925957/ https://www.ncbi.nlm.nih.gov/pubmed/35272440 http://dx.doi.org/10.3904/kjim.2021.527 |
Ejemplares similares
-
The Developing World Urgently Needs Phages to Combat Pathogenic Bacteria
por: Nagel, Tobi E., et al.
Publicado: (2016) -
The Urgent Need for Novel Antimicrobial Agents and Strategies to Fight Antibiotic Resistance
por: D’Andrea, Marco Maria, et al.
Publicado: (2019) -
Prospects for the Use of New Technologies to Combat Multidrug-Resistant Bacteria
por: Lima, Renata, et al.
Publicado: (2019) -
Boosting nanotoxicity to combat multidrug-resistant bacteria in pathophysiological environments
por: Westmeier, Dana, et al.
Publicado: (2020) -
WHO PUBLISHES LIST OF BACTERIA FOR WHICH NEW ANTIBIOTICS ARE URGENTLY NEEDED
Publicado: (2017)